Hematología y Hemoterapia

Resultados: 405
Tipo Título / Nombre Autor(es) Año
Eficacia y seguridad de eltrombopag en PTI secundaria en la práctica clínica González López TJ, Álvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Jarque I, et al 2015
Relationship between Antiphospholipid Syndrome clinical manifestations and multiple positive antiphospholipid antibodies. Sigüenza R, Bermejo N, Casas I, Ibañez F, Bañas MH, Bergua JM, et al 2015
CD38 expression on CD34+ Bone Marrow Cells (BM) as a tool in low grade Myelodysplactics Syndromes (MDS) Sigüenza R, Bañas MH, Casas I, Ibañez F, Bermejo N, Bergua JM, et al 2015
Eltrombopag may be useful in Secondary ITP patients in clinical practice González-Lopez JM, Alvarez-Roman MT, Pascual C, Sanchez-Gonzalez B, Fernandez-Fuentes F, Jarque I, et al 2015
Long-term anticoagulation with dabigatran in patients with severe lactose intolerance Bermejo N, Sigúenza R, Ibañez F, Bañas MH, Casas I, Pérez-Leal FA, et al 2015
Bleeding risk of surgery in patients with Inherited Platelet Function Disorders (IPFD): outcome of 389 surgeries in 205 patients Gresele P, Noris P, Orsini S, Heller P, Santoro C, Bury L, et al 2015
Role of mTOR1 and mTOR2 complexes in MEG-01 cell physiology López E, Berna-Erro A, López JJ, Granados MP, Bermejo N, Brull JM, et al 2015
Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm Batlle J, Pérez-Rodríguez A, Corrales I, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, et al 2015
Phase II study with conventional radiotherapy (RT) + cetuximab in patients with advanced larynx cancer who responded to induction chemotherapy (IC): An organ preservation TTCC study Mesia R, Garcia Saenz JA, Lozano A, Pastor M, Grau JJ, Martinez Trufero J, et al 2015
Azacitidine in older patients with acute myeloid leukemia (AML). Results from the ALMA study according to the MRC risk index score Falantes JF, Martinez Robles V, Bargay J, Deben G, Garrido A, Casano J, et al 2015